Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditions, including cancer and chronic inflammatory diseases.
General Information
BounceWatch is an independent company data service, not affiliated with Synta Pharmaceuticals. To contact Synta Pharmaceuticals, visit syntapharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Synta Pharmaceuticals compare?
A PDF of Synta Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Synta Pharmaceuticals soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Synta Pharmaceuticals
Business keywords: biopharmaceutical company, small molecule drugs, cancer treatment, chronic inflammatory diseases, drug discovery, clinical development, global partnership, Roche collaboration, lead optimization, autoimmune diseases, Hsp90 inhibitor, rheumatoid arthritis, medical innovations
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $38.50M | - |
|
01 Apr 2015 |
| Post IPO Equity | $3.75M | - |
|
19 Jan 2010 |
| Post IPO Equity | $23.10M | - |
|
08 Jan 2010 |
| Venture Round | $40.00M | - |
|
22 Oct 2006 |
| Series D | Undisclosed | - |
|
07 Dec 2004 |
| Series C | $50.00M | 6 |
|
14 Jan 2004 |
| Series B | $50.00M | - |
|
21 Apr 2003 |
| Venture Round | $12.00M | - |
|
31 May 2002 |
Synta Pharmaceuticals Alternatives & Competitors
View All Alternatives
Advancing healthcare innovations with targeted therapies for cancer, respiratory, and autoimmune dis...
Innovating to meet critical health challenges with advanced therapeutic discoveries and developments...
Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kinase inhibit...
FAQ About Synta Pharmaceuticals
Source: BounceWatch company record for Synta Pharmaceuticals, https://bouncewatch.com/company/synta-pharmaceuticals, updated 27 December 2024. When citing, please name BounceWatch and link this page.
